JP2012532859A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532859A5
JP2012532859A5 JP2012519080A JP2012519080A JP2012532859A5 JP 2012532859 A5 JP2012532859 A5 JP 2012532859A5 JP 2012519080 A JP2012519080 A JP 2012519080A JP 2012519080 A JP2012519080 A JP 2012519080A JP 2012532859 A5 JP2012532859 A5 JP 2012532859A5
Authority
JP
Japan
Prior art keywords
cells
fibroblasts
regulatory
stem cells
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532859A (ja
JP5892931B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/001968 external-priority patent/WO2011004264A1/en
Publication of JP2012532859A publication Critical patent/JP2012532859A/ja
Publication of JP2012532859A5 publication Critical patent/JP2012532859A5/ja
Application granted granted Critical
Publication of JP5892931B2 publication Critical patent/JP5892931B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519080A 2009-07-09 2010-07-09 細胞治療において使用するための方法および組成物 Active JP5892931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22427509P 2009-07-09 2009-07-09
US61/224,275 2009-07-09
PCT/IB2010/001968 WO2011004264A1 (en) 2009-07-09 2010-07-09 Methods and compositions for use in cellular therapies

Publications (3)

Publication Number Publication Date
JP2012532859A JP2012532859A (ja) 2012-12-20
JP2012532859A5 true JP2012532859A5 (enExample) 2013-08-15
JP5892931B2 JP5892931B2 (ja) 2016-03-23

Family

ID=42782196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519080A Active JP5892931B2 (ja) 2009-07-09 2010-07-09 細胞治療において使用するための方法および組成物

Country Status (19)

Country Link
US (1) US8679834B2 (enExample)
EP (2) EP2451943B1 (enExample)
JP (1) JP5892931B2 (enExample)
KR (1) KR101788885B1 (enExample)
CN (2) CN107007626A (enExample)
AU (1) AU2010269962B2 (enExample)
BR (1) BR112012000534A2 (enExample)
CA (1) CA2767300C (enExample)
DK (1) DK2451943T3 (enExample)
ES (1) ES2479542T3 (enExample)
HU (1) HUE031921T2 (enExample)
IL (1) IL217377A (enExample)
MX (1) MX359639B (enExample)
NZ (1) NZ597975A (enExample)
PL (1) PL2451943T3 (enExample)
PT (1) PT2451943T (enExample)
RU (1) RU2610427C2 (enExample)
SG (2) SG10201403758SA (enExample)
WO (1) WO2011004264A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
DK1926813T4 (da) 2005-09-23 2019-08-19 Tigenix S A U Cellepopulationer med immunregulatorisk aktivitet, fremgangsmåde til isolering og anvendelser
WO2011006029A1 (en) 2009-07-10 2011-01-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Artificial cell constructs for inducing immunological tolerance
US11090363B2 (en) 2009-07-10 2021-08-17 University of Pittsburgh—of the Commonwealth System of Higher Education Vasoactive intestinal peptide release from microparticles
US20140154274A1 (en) * 2011-01-12 2014-06-05 Tigenix Nv Methods and compositions for use in intralymphatic cellular therapies
HRP20181515T1 (hr) 2011-11-30 2018-11-16 Astellas Institute For Regenerative Medicine Mezenhimne stromalne stanice i upotreba povezana s njima
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
CN104822384A (zh) * 2012-03-30 2015-08-05 南加州大学 用于间充质干细胞诱导的免疫调节的组合物和治疗方法
WO2014011407A2 (en) 2012-07-12 2014-01-16 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
WO2016098061A1 (en) 2014-12-18 2016-06-23 Pluristem Ltd. Methods and compositions for treating and preventing muscle wasting disorders
WO2016107563A1 (zh) * 2014-12-29 2016-07-07 西比曼生物科技(上海)有限公司 一种用于治疗上呼吸道疾病的脂肪间充质祖细胞复合物
US20180015125A1 (en) 2015-03-23 2018-01-18 Pluristem Ltd. Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof
US20210205370A1 (en) 2016-02-18 2021-07-08 Pluristem Ltd. Methods and compositions for treating cancers and neoplasms
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US12161688B2 (en) 2016-06-30 2024-12-10 Mapi Pharma Ltd Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
AU2018270396B2 (en) 2017-05-15 2025-03-20 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells
WO2018211486A1 (en) 2017-05-15 2018-11-22 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
CN107281469A (zh) * 2017-07-17 2017-10-24 广东颜值科技有限公司 一种细胞组合物及其制备方法和应用
CN107349419A (zh) * 2017-07-17 2017-11-17 广东颜值科技有限公司 一种细胞组合物及其制备方法和应用
CN112912087A (zh) 2018-09-14 2021-06-04 卢卡科学株式会社 线粒体向淋巴器官中的移植以及用于该移植的组合物
JP2022527455A (ja) * 2019-03-19 2022-06-02 フィジーン、エルエルシー 活性化線維芽細胞及びそのエキソソーム誘導体を用いた慢性閉塞性肺疾患及び肺変性の治療
CA3142267A1 (en) * 2019-05-31 2020-12-03 Figene, Llc Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
WO2021207192A1 (en) * 2020-04-08 2021-10-14 Figene, Llc Methods and compositions for allergy and asthma treatment using fibroblasts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5068931B2 (ja) * 2002-07-12 2012-11-07 ザ ジョンズ ホプキンス ユニバーシティー 独自のクローン形質のリンパ球受容体に結合する試薬および方法
ATE486125T1 (de) * 2002-12-06 2010-11-15 Northwest Biotherapeutics Inc Verabreichung teilgereifter dendritischer zellen in vitro zur behandlung von tumoren
DK1926813T4 (da) 2005-09-23 2019-08-19 Tigenix S A U Cellepopulationer med immunregulatorisk aktivitet, fremgangsmåde til isolering og anvendelser
US8241621B2 (en) * 2006-12-18 2012-08-14 Medistem Laboratories Stem cell mediated treg activation/expansion for therapeutic immune modulation
AU2008287063B2 (en) * 2007-08-09 2013-10-24 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
EP2191835A4 (en) * 2007-09-07 2011-12-14 Japan Chem Res THERAPEUTIC AND PROPHYLACTIC AGENTS FOR ARTHRITIS
EP2279246A4 (en) * 2008-05-02 2012-03-28 Massachusetts Inst Technology METHOD AND COMPOSITIONS FOR MODULATING IMMUNOLOGICAL TOLERANCE
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells

Similar Documents

Publication Publication Date Title
JP2012532859A5 (enExample)
RU2012104529A (ru) Способы и композиции для применения в клеточной терапии
Julier et al. Promoting tissue regeneration by modulating the immune system
Gao et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure
MX2012002082A (es) Terapia de acetato de glatiramero de baja frecuencia.
ES2479544T1 (es) Células madre mesenquimales derivadas de tejido adiposo para administración intralinfática en enfermedades autoimmunes e inflamatorias
JP2012041342A5 (enExample)
JP2014502628A5 (enExample)
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
BR112014018485A8 (pt) Uso de laquinimod para tratar pacientes com a doença de crohn que falharam com a primeira linha de terapia anti-tnf
SI2625199T1 (en) Procedures for treating psoriasis using IL-17 antagonists
JP2014528901A5 (enExample)
EA201490911A1 (ru) Способы лечения злокачественных опухолей с использованием пероральных составов аналогов цитидина
BR112014027010A2 (pt) uso de laquinimod de alta dose para tratamento de esclerose múltipla
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
RU2014122858A (ru) Лечение когнитивных расстройств (r)-7-хлор-n-(хинуклидин-3-ил)бензо[в]тиофен-2-карбосамидом и его фармацевтически приемлемыми солями
Wen et al. Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
RU2015116264A (ru) Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
RU2012136724A (ru) Лечение или профилактика инфекции
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
RU2009101026A (ru) Применение тимозина-альфа-1 для получения лекарственного средства для лечения злокачественной меланомы на iv стадии
Millar et al. Frozen shoulder (Primer)
WO2019241742A8 (en) Combination of ezh2 inhibitor and checkpoint therapy for the treatment of cancer